![Get Involved [Button]](/templates/ecef/images/get-involved_btn.gif)
ARE YOU AT RISK FOR EC?
FOLFOX plus cetuximab produced ORR of 77% in cardia, esophageal cancer
Sunday, 23 January 2011 06:21
SAN FRANCISCO – Chemoradiation with FOLFOX and cetuximab was effective in adults with locally advanced cardia and esophageal cancer in a phase 2 study, according to Aimery de Gramont, MD. Now, researchers want to see the regimen evaluated in a phase 3 trial.
Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility
© Copyright 2012. ECEF. All rights reserved.
